Cost Savings Related to Qualifying Cell and Gene Therapy Facilities

  • Share:

Viral vector and cell/gene therapy facilities can be less complicated and require fewer critical utilities when compared to pharmaceutical or biotech facilities. Such facilities frequently do not have specialized requirements such as low particulate levels or high-quality water systems as many processes are small-scale and enclosed. Viral vector facilities usually require multiple laboratories to perform assays and rooms to house controlled temperature units that require nothing more than adequate power and controlled classified environments. This webinar will discuss risk assessment and qualification that is phase-appropriate for your CGT operation.

Complete the form below to access the on-demand webinar:

  • Share:

Contact Us

Let’s Get Started

Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.



22320 Foothill Blvd. Suite 330, Hayward CA 94541